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Abstract
Catalytically defective rare variants of Sialic acid Acetyl Esterase (SIAE) have previously been linked to autoimmunity. Studies
presented here confirm that the M89V SIAE protein and all other products of common variant alleles of SIAE are catalytically
normal. Although overexpressing transfected non-lymphoid cells secrete small amounts of SIAE that can associate with the
cell surface, normal human lymphocytes do not exhibit cell surface SIAE, supporting genetic evidence in mice that indicates
that this protein functions in a lymphocyte intrinsic manner. Analyses of the plasma proteome also indicate that SIAE is not
secreted in vivo. A re-analysis exclusively of catalytically defective rare variant alleles of SIAE in subjects in which this gene
was completely sequenced confirmed an association of SIAE with autoimmunity. A subset of catalytically defective rare
variant SIAE alleles has previously been typed in a large genotyping study comparing a diverse group of disease subjects
and controls; our re-analysis of this data shows that catalytically defective alleles are enriched in disease subjects. These data
suggest that SIAE may be associated with autoimmunity and that further study of catalytically defective rare variant SIAE
alleles in terms of autoimmune disease susceptibility is strongly warranted.
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Introduction
Sialic acid acetyl esterase (SIAE) removes acetyl moieties from
the 9-OH position of sialic acid, and thus permits a2,6 linked sialic
acid on N-glycans on B cell glycoproteins to interact with CD22/
Siglec-2, a sialic acid binding lectin that can inhibit B cell antigen
receptor signaling [1–3]. Mice with an engineered defect in Siae
exhibited enhanced B cell receptor (BCR) signaling, B cell
differentiation defects that are consistent with enhanced BCR
signaling, circulating anti-chromatin antibodies and immune
complex deposits in the kidney [1].
We showed in overexpression studies that SIAE can be secreted
and decorate the surface of over-expressing transfected non-
lymphoid cells presumably by binding to some extracellular
component but the physiological relevance of secretion and cell
surface expression of this protein was not critically evaluated by
in vivo studies [1]. Clearly this protein must function in a post
Golgi compartment since a2–6 linked sialic acids moieties are
added and acetylated in the 9-OH position in the trans-Golgi. Our
previous studies involving the reconstitution of Rag-1 mutant mice
with bone marrow from wild type and siae mutant mice had
suggested that this gene functions in a B lymphocyte intrinsic
manner [1]. Although SIAE is expressed in many different tissues,
this result indirectly argued against an in vivo role for secreted
SIAE.
Catalytically defective heterozygous rare variants of SIAE were
shown by us to be linked to autoimmune disorders [4,5]. Although
overexpressed wild type SIAE protein was detected in the
supernatants of transfected 293T cells, all disease related
catalytically defective SIAE proteins expressed in 293T cells
exhibited a failure of secretion potentially because these proteins
are partly misfolded and are thereby retained in the endoplasmic
reticulum (ER).
A catalytically normal common variant of SIAE, c.265 A.G
(M89V) SIAE is seen in heterozygous form in approximately 10%
of control subjects (Table 1), and in our original studies was
identified in homozygous form in 6/923 subjects with autoimmu-
nity and 0/654 controls [4]. In the course of overexpression
studies, a recreated human M89V SIAE protein was shown to be
catalytically active, was incapable of inhibiting the activity of the
wild type SIAE protein, but was poorly secreted when overex-
pressed. Although we had assumed that M89V SIAE may be
defective in spite of being catalytically normal, it has become
important to determine whether secretion of wild type SIAE
occurs in vivo, and if human lymphocytes express SIAE on the cell
surface, in order to determine if secretion alone is a valid assay for
PLOS ONE | www.plosone.org 1 January 2013 | Volume 8 | Issue 1 | e53453SIAE function and to thus assess if the M89V allele is indeed in
any way defective.
The most detailed publicly available catalogue of exome
sequencing (not annotated to distinguish between controls and
disease subjects, but stratified by ancestry), is the NHLBI Exome
Variant Server (http://evs.gs.washington.edu/EVS/). The exam-
ination of this unannotated data indicates that about 0.3% of
Caucasians are homozygous for M89V SIAE. Examination of
larger sets of subjects by genotyping has revealed that homozy-
gosity of M89V SIAE is frequently observed in controls [6,7]. In a
large genotyping study [7], examining a mixture of autoimmune,
inflammatory and allergic disorders, it was claimed that SIAE was
not linked to autoimmunity. Our re-analysis of the data from that
study on an allele by allele basis (presented below) indicates that
catalytically defective SIAE alleles are indeed enriched in subjects
with disease. We also examined the catalytic activity of all
common variants of SIAE to determine if any common variant
should be considered in terms of disease susceptibility.
Materials and Methods
Ethics Statement
All human studies were approved by the Institutional Review
Board at Massachusetts General Hospital.
Site-directed Mutagenesis of Human and Murine SIAE
cDNA
Full-length C-terminal Flag-tagged human and murine SIAE
cDNAs were targeted for PCR based mutagenesis using Pfu Turbo
DNA polymerase (Agilent). The K71R and A467V SIAE variants
were re-created on a human SIAE cDNA in a pcDNA3.1 based
mammalian expression construct. M89V and the two rare murine
Siae variants, C196F and Q335P (murine equivalent of human
Q309P SIAE) were re-created in a murine Siae cDNA. Primers (59
to 39) for site-directed mutagenesis were designed based on
ENST00000263593 (human) and ENSMUST00000002007
(mouse). The PCR products were digested with Dpn I restriction
enzyme (Agilent) and transformed into TOP10 chemically
competent E. coli cells (Invitrogen). Clones harboring the desired
single nucleotide change were verified by DNA sequencing.
Assays for SIAE Enzyme Activity
Assays for SIAE enzyme activity have been reported by us
previously [4]. Briefly, each of the SIAE variants (K71R, A467V,
M89V, C196F and Q335P (murine equivalent of human Q309P))
were transfected transiently in HEK 293T cells, in parallel to
cDNA’s encoding wild type (WT) and S127A (catalytically inert)
proteins. Cell lysates were immunoprecipitated with monoclonal
anti-Flag antibodies (Sigma) and catalytic activity of immunopre-
cipitated SIAE was assayed using 4-methylumbelliferyl acetate
(USB). Equivalent amounts of cell lysate were immunoprecipitated
for the enzyme activity assay, and for quantification of the protein
by a quantitative Western blot assay on the LI-COR Odyssey
imaging system, using an IR Dye 800 CW labeled Goat anti-
mouse IgG as the secondary antibody.
Metabolic Labeling and Pulse Chase Studies
HEK 293T cells transfected with cDNAs encoding WT, K71R
and A467V SIAE were starved for 1 h in methionine/cysteine-free
medium and labeled with 0.5 mCi of
35S-methionine for 10 min.
Cells were either lysed immediately (10 min) or after 2 and 4 hrs of
chase with an excess of complete medium. Lysates were
immunoprecipitated with anti-Flag antibodies and protein A
sepharose beads (Sigma). Proteins were separated by SDS/PAGE
(8%) and revealed by autofluorography.
Characterization of an Anti-SIAE Antibody by
Immunoprecipitation and Flow Cytometry
293T human embryonic kidney cells, and the BJAB and Ramos
B cells lines (ATCC) were used for characterization of a polyclonal
anti-SIAE antibody (Novus Biological, H00054414-B01P). 293T
cells were transfected with human Flag-tagged SIAE. Cell lysates
were immunoprecipitated with anti-SIAE (3 mg), isotype control
Mouse IgG (3 mg) (BD Biosciences), or anti-Flag (3 mg) antibodies.
Immunoprecipitated samples were analyzed by Western blotting
using anti-SIAE (1:1000) (three hours to overnight) or anti-Flag
(1:1000) antibodies and subsequent incubation with anti-Mouse
IgG-HRP (1:20,000) for 1hour. BJAB and Ramos cells were fixed
with 2% paraformaldehyde in PBS for 5 minutes at room
temperature. The cells were permeabilized with 0.02% Triton-X-
100 in 1xPBS-05%BSA (PBS-BSA) for 7 minutes at room
temperature. Cells were then incubated with anti-SIAE (3 mg) or
isotype control Mouse IgG (3 mg) for 45 minutes at 4uC. The
secondary antibody Goat anti-Mouse IgG-FITC (BD Biosciences)
was incubated for 40 minutes at 4uC. The cells were washed twice
and resuspended with PBS-BSA for flow cytometric analysis.
Examination of SIAE Intracellularly and on the Cell
Surface of Human Lymphocytes by Flow Cytometry
Human white blood cells were isolated and examined separately
for the presence of surface or intracellular SIAE. Peripheral blood
Table 1. Non-synonymous common variants of SIAE in subjects of European ancestry.
1
Coding change Sequence Variant Genotype
Surolia et al (4) Frequency
(%)
n=1571 EVS Frequency (%)
dbSNP Frequency (%)
n=1089
G64S c.190G.A G/A 0.6365 0.7385* 3.33
K71R c.212A.G A/G 1.655 12.0615* 9
M89V c.265A.G A/G 8.466 7.9077* 2.7
M89V c.265A.G G/G 0.5092 0.3024**
A467V c.1400C.T C/T 0.7002 4.3385* 2.3
1The subjects from Surolia et al. (4) include controls and autoimmune subjects of European ancestry. EVS (Exome variant server) data comprises unannotated American
subjects (disease status is unknown) of European and African ancestry and is current as of June 20th 2012. Variants reported in both African-Americans and European-
Americans are marked with a single asterisk (*n=6500). Variants seen only in European-Americans or only in African-Americans are marked with double (**n=4299) and
triple asterisks (***n=2201) respectively. The dbSNP data is not ethnically stratified and was derived from the 1000 genomes project.
doi:10.1371/journal.pone.0053453.t001
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11
Coding change
Sequence
Variant
Surolia et al. (4)
Frequency (%) n=1571
Hirschfield et al. (5)
Frequency (%) n=381 EVS Frequency (%) n=4299
1) A3G c.8C.G 0.0636 0.5452 ***
2) R27H c.80G.A 0.0454 ***
3) Y31C c.92A.G 0.0909 ***
4) N33S c.98A.G 0.0636
5) A45S c.133G.T 0.0465 **
6) W48X c.143G.A 0.0636
7) R62H c.185G.A 0.0233 **
8) T81M c.242C.T 0.0454 ***
9) P91R c.272C.G 0.0154 **
10) E96K c.286G.A 0.0909 ***
11) Q101K c.301C.A 0.0909 ***
12) N107K c.321C.G 0.0930 **
13) A147V c.440C.T 0.0465 **
14) S158F c.286C.T 0.0454 ***
15) Q161K c.481C.A 0.0636
16) A171V c.512C.T 0.1363 ***
17) C196F c.587G.T 0.191 0.0462 *
18) F199C c.596T.G 0.7874
19) R201H
nf c.602G.A
20) R201C c.601C.T 0.2726 ***
21) T206I c.617C.T 0.0465 **
22) P210L c.629C.T 0.0154 **
23) G212R c.634G.A 0.0636 0.0698 **
24) S228C c.683C.G 0.0454 ***
25) R230W c.688C.T 0.0636
26) D246N c.736G.A 0.1817 ***
27) P251L c.752C.T 0.0233 **
28) S255A c.763T.G 0.0233 **
29) C266G c.796T.G 0.0636
30) Y276H c.826T.C 0.0233 **
31) T286M c.857C.T 0.0154 *
32) L296F c.886C.T 0.0233 **
33) Q309P c.926A.C 0.0636
34) T312M c.935C.T 0.1273 0.2625 0.0154 *
35) R314H c.941G.A 0.0636 0.0454 ***
36) L323F c.969A.C 0.1363 ***
37) S325P
nf c.973T.C
38) D334N c.1000G.A 0.0454 ***
39) R340H c.1019G.A 0.0909 ***
40) W341X
nf c.1022G.A
41) G348S c.1042G.A 0.0454 ***
42) Y349C c.1046A.G 0.0636
43) P356L c.1067C.T 0.2625
44) N357S c.1070A.G 0.0233 **
45) L366V c.1096C.G 0.0233 **
46) R369K c.1106G.A 0.0233 **
47) D370H c.1108G.C 0.0233 **
48) S371L c.1112C.T 0.0233 **
49) Q382R c.1145A.G 0.2625
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using hypotonic water lysis, followed by dilution with 10 X HBSS
and two washes with PBS-BSA. For extracellular staining, unfixed
or fixed PBMC were incubated with anti-SIAE (3 mg) or Isotype
control Mouse IgG (3 mg) followed by a secondary antibody, FITC
labeled anti-Mouse IgG. CD8-APC-cy7 (BD Biosciences) was used
as a control for both extracellular and intracellular staining. For
intracellular staining of PBMC the method was the same as
described above for the BJAB and Ramos cell lines.
Results
A Large Number of Novel Non-synonymous Rare Variants
of SIAE have been Discovered by Exome Sequencing
We originally described 19 rare variants of SIAE of which 11
were catalytically defective [4). Rare variants are arbitrarily
defined as having a frequency below 1% in the population. In a
study on primary biliary cirrhosis, three additional rare variants of
SIAE were identified of which two were shown to be defective [5].
Unannotated exome sequencing studies that are reported on the
Exome Variant Server (controls and disease subjects are not
distinguished) have revealed a number of non-synonymous rare
variants of SIAE. A list of SIAE rare variants that have been
identified so far in subjects of European and African- American
ancestry is included in Table 2. The very large and growing
number of rare variants of SIAE suggests that genotyping studies
would be most useful if all possible defective variants are
genotyped in order to obtain detailed information regarding
susceptibility. Sequencing of all exons of this gene is required in
order to accurately identify rare genetic variants. Functional
studies on all identified rare variants will most accurately identify
those that should be considered relevant to quantify in disease
subjects and controls.
Pulse-chase Studies Reveal Minimal Secretion of
Overexpressed SIAE Proteins
All variants that are at a frequency above the threshold set for
rare variants are considered to be common variants. A total of four
non-synonymous common variants of SIAE were identified in the
course of our studies, and all four have also been observed in
subsequent exome sequencing approaches (Table 1). We have
previously analyzed G64S SIAE and M89V SIAE [4], both of which
encode catalytically normal proteins, though the latter variant was
initially assumed to be defective on the basis of defective secretion
upon overexpression and this criterion clearly deserves further
analysis as discussed in the Introduction. An examination of K71R
SIAE and A467V SIAE revealed that they were both catalytically
active (Fig. 1), catalytic activity being well above the 50%
threshold previously set [4]. We decided to examine the
proportion of wild type SIAE, K71R SIAE and A467V SIAE
that is secreted in the course of metabolic labeling and pulse-chase
studies to indirectly gauge the relevance of protein secretion as an
assay for SIAE function. As seen in Fig. 2, over a 4 hour chase
period, miniscule amounts of wild type SIAE, K71R SIAE and
A467V SIAE were actually secreted suggesting that while the
absence of secretion at steady-state may correlate well with a
Table 2. Cont.
Coding change
Sequence
Variant
Surolia et al. (4)
Frequency (%) n=1571
Hirschfield et al. (5)
Frequency (%) n=381 EVS Frequency (%) n=4299
50) A385T c.1153G.A 0.0909 ***
51) R387W c.1159C.T 0.0233 **
52) R393C c.1177C.T 0.0909 ***
53) R393H c.1178G.A 0.0636
54) A394T c.1180G.A 0.0233 **
55) F404S c.1211T.C 0.2546 0.5249 0.0698 **
56) G419E
nf c.1256G.A
57) Q428L
nf c.1283A.T
58) K434T c.1301A.C 0.0233 **
59) C443R
nf c.1340A.G
60) H447R c.1340A.G 0.0636 0.0454 ***
61) M456T c.1367T.C 0.0636 0.0454 ***
62) M456I c.1368G.A 0.0636
63) V459I
nf c.1375G.A
64) Q462R c.1385A.G 0.0636 0.0698 **
65) H472Q c.1416T.A 1.3176 ***
66) R479C c.1435C.T 0.0636 0.0233 **
67) G514A c.1541G.C 0.0233 **
11The subjects from Surolia et al. (4) and Hirschfield et al. (5) include controls and autoimmune subjects of European ancestry. EVS (Exome variant server) data
comprises unannotated American subjects (disease status is unknown) of European and African ancestry and is current as of June 20th 2012. Rare variants reported in
both African-Americans and European-Americans are marked with a single asterisk (*n=6500). Rare variants seen only in European-Americans or only in African-
Americans are marked with double (**n=4299) and triple asterisks (***n=2201) respectively.
nfThese variants were found in dbSNP and/or 1000 genomes project but frequency data is not available. The dbSNP data is not ethnically stratified and was derived from
the 1000 genomes project.
doi:10.1371/journal.pone.0053453.t002
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of SIAE alone may not be a suitable measure of its function.
SIAE is Expressed by Human Lymphocytes but does not
Decorate the Cell Surface
SIAE was originally purified from the liver [8], and it is
expressed in cells other than B cells. Detailed proteomic analysis of
all plasma proteins as well as of shed human proteins that
accumulate at detectable levels in the plasma have been
performed. These studies have failed to reveal the presence of
even a trace of SIAE in human plasma [9,10], indicating that
SIAE is likely not secreted in vivo. These studies strongly suggest
that the secretion of SIAE is likely an in vitro artefact. The cell
intrinsic function of this protein in murine B cells is consistent with
its expression intracellularly in B lymphocytes. We characterized
polyclonal antibodies to SIAE to establish their specificity and to
determine whether they were capable of recognizing native
protein in immunoprecipitation and flow cytometric studies. As
seen in Figures 3A and B, these polyclonal anti-SIAE antibodies
can immunoprecipitate overexpressed human SIAE as well as the
anti-Flag antibody, and the polyclonal antibodies can also
immunoprecipitate endogenous human SIAE. Flow cytometry
reveals the presence of endogenous intracellular SIAE in human
BJAB and Ramos B cell lines (Fig. 3C).
Flow cytometric studies of human peripheral blood monoc-
nuclear cells (Fig. 4) reveal that SIAE is expressed intracellularly
but not on the surface of human white blood cells in the
lymphocyte gate suggesting that this enzyme mediates its functions
at an intracellular location. This result is consistent with our
previous published results indicating that murine Siae functions in
a cell-intrinsic manner in B lymphocytes [1].
Both Murine and Human M89V SIAE Encode Catalytically
Normal Enzymes
To better analyze whether the M89V SIAE common variant
exhibits an alteration in function, we decided to extend our studies
across a species barrier. Human and murine SIAE are not
identical (the human protein lacks a 26 amino acid stretch present
in rodents) so we determined whether defective human SIAE
variants are also catalytically defective when re-created in a
murine cDNA. All disease related catalytically defective SIAE
variants tested were defective when re-created in the murine
Figure 2. Metabolic labeling and pulse-chase analysis comparing the secretion of wild type SIAE with K71R and A467V SIAE
proteins. HEK 293T cells transfected with cDNAs encoding WT, K71R and A467V SIAE were pulse labeled with
35S-methionine and lysates and
supernatants were immunoprecipitated with anti-Flag antibodies after 10 min, 2 hrs and 4 hrs of chase. Proteins were separated by SDS/PAGE and
revealed by autofluorography. The position of molecular weight markers is indicated on the left in kilodaltons (kDa). (A) A comparison of wild type
and A467V SIAE proteins. (B) A comparison of wild type and K71R SIAE proteins.
doi:10.1371/journal.pone.0053453.g002
Figure 1. K71R SIAE and A467V SIAE proteins are functionally normal. The K71R and A467V SIAE variants were re-created by site-directed
mutagenesis. Wild type (WT) SIAE, a known catalytic site mutant (S127A SIAE), and the two SIAE common variants were transfected into HEK 293T cells.
Half of each cell lysate was immunoprecipitated with anti-Flag antibodies and revealed in a quantitative Western blot assay (A) and the other half was
similarly immunoprecipitated and examined for esterase activity, presented following normalization for lysate SIAE protein content (B). Each mutant
was separately transfected and analyzed on three occasions. A representative experiment is shown. Error bars reflect esterase assays performed in
triplicate in a single experiment.
doi:10.1371/journal.pone.0053453.g001
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Q309P SIAE). Both catalytically defective disease-related murine
proteins were not secreted in these overexpression studies.
However overexpressed murine M89V Siae (unlike human M89V
SIAE) was secreted as well as its wild type murine counterpart and
like its human counterpart was catalytically normal (Fig. 5). For all
these reasons, we believe that only catalytically defective SIAE
alleles should be compared between disease and controls groups to
assess the relevance of this gene is terms of disease susceptibility.
Catalytically Defective SIAE Alleles may be Linked to
Disease
Re-analysis of our original sequencing data examining only the
frequency of confirmed catalytically defective SIAE alleles in
controls and subjects revealed that catalytically defective SIAE
Figure 3. Detection of endogenous and overexpressed SIAE in the native state using a polyclonal anti-SIAE antibody. 293T cells were
transfected with Flag-tagged SIAE or left untransfected as a negative control. The IgG heavy chain (IgG HC) was seen in all immunoprecipitated
samples. (A) Cell lysates were immunoprecipitated with anti-Flag antibodies and analyzed by Western blotting using polyclonal anti-SIAE. An SIAE-
GST fusion protein was run in the third lane as a positive control. (B) Cell lysates in both panels were immunoprecipitated with anti-SIAE, IgG and anti-
Flag. The left panel displays the use of anti-SIAE for Western blotting. The immunoprecipitated samples in this panel reveal both overexpressed and
endogenous SIAE. Immunoprecipitated proteins in the right panel were revealed by an anti-Flag Western blot. (C) Endogenous SIAE levels were
further characterized in the B cell lines BJAB (left) and Ramos (right) by flow cytometric analysis. The data are all representative of three independent
experiments.
doi:10.1371/journal.pone.0053453.g003
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(95% confidence intervals 1.3684 to 9.0317) and a two tailed p
value by Fisher’s exact test of 0.0077 (Table 3). Hunt et al. chose
to genotype 8 of the 11 catalytically defective SIAE alleles that we
had originally described, in a large number of subjects with a
variety of diverse autoimmune, allergic, and inflammatory
disorders. Interestingly the most frequent but defective rare
variant of SIAE, T312M SIAE, was not genotyped in their studies.
This selected subset of catalytically defective rare variants were
genotyped in a total of 30, 618 disease subjects from different
European cohorts including 22, 718 from the UK. They were
compared with a total of 12, 739 control subjects including 8, 274
from the UK. This represents the largest body of genotyping
evidence available for catalytically defective SIAE alleles – even
though a substantially large number of catalytically defective SIAE
alleles clearly remain to be genotyped. An analysis of this data,
allele by allele as well as for all catalytically defective SIAE alleles
shows a discernible enrichment of catalytically defective SIAE
alleles with the diverse set of diseases included in the analysis
(Table 4), and some alleles such as SIAE R479C revealed relatively
strong Odds Ratios. Statistical significance could not be revealed
in these studies given the low frequencies of rare variants (the two
tailed p value even for R479C SIAE using Chi square analysis with
Yates correction was 0.1995), however these results suggest that it
would be premature to assume that catalytically defective SIAE
alleles are not associated with disease. Keeping in mind that all the
catalytically defective rare variants are present at a very low
frequency, the inclusion of even a single high frequency
catalytically normal common variant can skew the overall analysis
and hinder the detection of associations linked to defective rare
variants.
Discussion
The number of catalytically defective rare variants of SIAE
originally described by us represents a small subset of the defective
rare variants in this gene as revealed by our own subsequent
sequence analyses and by exome sequencing studies that have
been undertaken subsequent to our original publication. The vast
majority of the rare genetic variants of SIAE identified by
sequencing following our original report represent newly discov-
Figure 4. Wild type SIAE is not expressed on the surface of human peripheral blood mononuclear cell (PBMCs). (A) Flow cytometric
analysis of SIAE was performed on unfixed non-permeabilized human PBMC demonstrating the absence of SIAE on the surface of any cells in the
lymphocyte gate. (B) The analysis of extracellular CD8 on unfixed, non-permeabilized PBMCs (left) and on fixed, permeabilized PBMCs (right) was used
as a positive control for extracellular and intracellular staining. (C) SIAE is expressed intracellularly in peripheral blood mononuclear cells. In the left
panel, cells were first stained extracellularly with anti-SIAE, washed, and then subjected to fixation and permeabilization prior to analysis. In the right
panel, flow cytometry of PBMC for intracellular SIAE was performed on cells that were fixed, permeabilized and then stained with anti-SIAE (black),
with an isotype control (blue) or with no antibodies (red).
doi:10.1371/journal.pone.0053453.g004
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this gene will likely be very large. There are currently 67
documented rare variants of SIAE and this number is rapidly
growing (Table 2).
A very small fraction of overexpressed wild type SIAE is
secreted as revealed in pulse-chase studies, and this minimal
secretion observed is an in vitro phenomenon of no proven
physiological significance. SIAE is not expressed on the surface of
human lymphocytes, and has not been detected in human plasma
by sensitive means. Secretion of SIAE per se should not be a
criterion for the function of this enzyme. Overexpressed murine
M89V SIAE is no different from wild type overexpressed protein,
and M89V SIAE in both humans and mice is catalytically normal.
On these grounds M89V SIAE should be unequivocally excluded
from considerations of disease susceptibility. The failure of
secretion of overexpressed mutant catalytically defective SIAE
proteins in transfected cells is likely a feature of misfolded mutant
proteins that fail to egress the ER – and therefore cannot
contribute even to the miniscule in vitro escape from the cell. The
likelihood that these disease associated mutant proteins are
misfolded is currently being explored using circular dichroism
spectroscopy.
Re-analysis of our data [4] excluding M89V SIAE from analysis,
reveals that defective variants of SIAE remain associated with
autoimmunity, with strong Odds Ratios, but our overall numbers
are relatively small compared to those used in the genotyping
study of Hunt et al. [7]. Re-analysis of the data of Hunt et al. [7]
including only data on the 8 catalytically defective SIAE rare
variants that they chose to genotype shows that these rare variants
are enriched in the diverse disease cohorts they analyzed (Table 4)
and these data do not support the notion that there is necessarily a
failure of association of catalytically defective SIAE alleles with
disease.
The analysis of rare genetic variants of any gene will require
large scale sequencing analyses followed by functional analyses of
novel variants. Large-scale genotyping studies of individual
variants may be required in order to attain statistically significant
results for any given rare variant allele. Large population studies
are currently being carried out with a full sequence analysis of the
SIAE locus followed by analyses of catalytic function in order to
identify a large proportion of defective rare variants of SIAE that
may be relevant to disease. A wide variety of diseases some
allergic, others autoimmune, some neither, were grouped
together in the study of Hunt et al. Very large genotyping
studies even larger than the one conducted by Hunt et al., but
including all known catalytically defective alleles may well
provide important information when carried out in well-defined
disease populations.
Figure 5. Murine M89V Siae is functionally normal. Murine Siae cDNAs encoding WT, S127A, M89V, C196F and Q335P (murine equivalent of
human Q309P SIAE) were introduced transiently into HEK 293T cells. Half of each lysate was immunoprecipitated with anti-Flag antibodies revealed in
a Western blot assay (A, Lysate). The culture supernatants were also subjected to immunoprecipitation with anti-Flag antibodies to reveal the extent
of secretion of each Siae variant at steady state (A, Supernatant). The other half of the cell lysate was similarly immunoprecipitated and examined for
esterase activity, presented following normalization for lysate SIAE protein content (B). Each mutant was separately transfected and analyzed on three
occasions. A representative experiment is shown. Error bars reflect esterase assays performed in triplicate in a single experiment.
doi:10.1371/journal.pone.0053453.g005
Table 3. Frequency of catalytically defective rare variants in
autoimmune subjects and controls determined by complete
sequencing [4].
Autoimmune
subjects Controls Odds Ratio P value
16/923 2/648 3.5155 (1.3684 to
9.0317)
0.0077
doi:10.1371/journal.pone.0053453.t003
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